Unresolved issues regarding the role of apoptosis in the pathogenesis of ischemic injury and heart failure

Journal of Molecular and Cellular Cardiology

Volumn 32, Issue 5, 2000, Pages 711-724

  Elsässer, Albrecht ^a   Suzuki, Keisuke ^b   Schaper, Jutta ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANNEXIN; CASPASE; DNA; DNA FRAGMENT; PROTEIN BAX; PROTEIN BCL 2;

APOPTOSIS; CELL DEATH; CELL PROTECTION; ENZYME ACTIVATION; HEART FAILURE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HUMAN; MITOCHONDRION; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW;

EID: 0033837033     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.2000.1125     Document Type: Review

References (110)

1. Apoptosis, oncosis and necrosis
2. The nomenclature of cell death: Recommendations of an ad hoc committee of the Society of Toxicologic Pathologists
3. Apoptosis: A basic biological phenomenon with wide ranging implications in tissue kinetics
4. Hibernating myocardium
5. The role of cell death in heart failure
6. 'Apoptotic' myocytes in the infarct area in rabbit hearts may be oncotic myocytes with DNA fragmentation: Analysis by immunogold electron microscopy combined with in situ nick end labeling
7. Significance of myocytes with positive DNA end-labeling (TUNEL) in hearts with dilated cardiomyopathy
8. Stretch-mediated release of angiotensin II induces myocyte apoptosis by activating p53 that enhances the local renin-angiotensin system and decreases the Bcl-2 to Bax protein ratio in the cell
9. A simple fluorescence method for surface antigen phenotyping of lymphocytes undergoing DNA fragmentation
10. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation
11. DNA double strand breaks measured in individual cells subjected to gel electrophoresis
12. Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. Involvement of the sphingolipid signaling cascade in cardiac cell death
13. Presence of double-strand breaks with single-base 3' overhangs in cells undergoing apoptosis but not necrosis
14. Monoclonal antibody to single-stranded DNA is a specific and sensitive cellular marker of apoptosis
15. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation
16. Evaluation of glucocorticoid-induced DNA fragmentation in mouse thymocytes by flow cytometry
17. An ELISA for detection of apoptosis
18. Identification of the ICE/CED-3 protease necessary for mammalian apoptosis
19. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: Inhibition by overexpression of Bcl-2 and Abl
20. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE
21. Caspase-3-generated fragment of gelsolin: Effector of morphological change in apoptosis
22. The CED-3/ICE-like protease Mch2 is activated during apoptosis and cleaves the death substrate lamin A
23. Intracellular adenosine triphosphate (ATP) concentration: A switch in the decision between apoptosis necrosis
24. Reperfusion injury induces apoptosis in rabbit cardiomyocytes
25. Apoptosis in ischemic and reperfused rat myocardium
26. Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats
27. Coronary artery constriction in rats: Necrotic and apoptotic myocyte death
28. Apoptosis and myocardial infarction
29. Co-localization of the cysteine protease caspase-3 with apoptotic myocytes after in in vivo myocardial ischemia and reperfusion in the rat
30. Ischemic heart disease and apoptosis
31. DNA fragmentation of human infarcted myocardial cells demonstrated by the nick end labeling method and DNA agarose gel eletrophoresis
32. Preconditioning rabbit cardiomyocytes: Role of pH, vacuolar proton ATPase, and apoptosis
33. Ischemic preconditioning reduces apoptosis by upregulating anti-death gene Bcl-2
34. Ischemic preconditioning decreases apoptosis in rat hearts in vivo
35. Ischemic preconditioning reduces neutrophil accumulation and myocardial apoptosis
36. Acute myocardial infarction in humans is associated with activation of programmed myocyte cell death in the surviving portion of the heart
37. Apoptosis in human acute myocardial infarction
38. Proliferating cell nuclear antigen (PCNA) and apoptosis in hyperacute and acute myocardial infarction
39. Expression of bcl-2 protein, an inhibitor of apoptosis, and Bax, an accelerator of apoptosis, in ventricular myocytes of human hearts with myocardial infarction
40. The variable morphological coexistence of apoptosis and necrosis in human myocardial infarction: Significance for understanding its pathogenesis, clinical course, diagnosis, and prognosis
41. Hibernating myocardium - An incomplete adaptation to ischemia
42. Cardiomyocyte remodeling during myocardial hibernation and atrial fibrillation: Prelude to apoptosis
43. Quantification of cardioprotective gene expression in porcine short-term hibernating myocardium
44. Myocardial cell death and apoptosis in hibernating myocardium
45. Apoptosis is initiated during ischemia and completed during reperfusion
46. Hypoxia induces apoptosis with enhanced expression of Fas antigen messenger RNA in cultured neonatal rat cardiomyocytes
47. Hypoxia-activated apoptosis of cardiac myocytes requires reoxygenation or a pH shift and is independent of p53
48. Oxidative stress developed during the reperfusion of ischemic myocardium induces apoptosis
49. Regulation of cardiomyocyte apoptosis in ischemia reperfused mouse heart by glutathione peroxidase
50. Signaling pathways in reactive oxygen species-induced cardiomyocyte apoptosis
51. Inhibition of copper-zinc superoxide dismutase induces cell growth, hypertrophic phenotype, and apoptosis in neonatal rat cardiac myocytes in vitro
52. Hypoxia-reoxygenation-induced apoptosis in cultured adult rat myocytes and the protective effect of platelets and transforming growth factor-beta(1)
53. Glucose uptake and glycolysis reduce hypoxia-induced apoptosis in cultured neonatal rat cardiac myocytes
54. The bcl-2 gene product prevents programmed ceil death of ventricular myocytes
55. The role of mitochondria in the salvage and the injury of the ischemic myocardium
56. The mitochondrial apoptotic pathway is activated by serum and glucose deprivation in cardiac myocytes
57. Regulation of Bcl-2 family proteins during development and in response to oxidative stress in cardiac myocytes
58. Inhibition of p38 mitogen-activated protein kinase decreases cardiomyocyte apoptosis and improves cardiac function after myocardial ischemia and reperfusion
59. Possible involvement of stress-activated protein kinase signaling pathway and Fas receptor expression in prevention of ischemia/reperfusion-induced cardiomyocyte apoptosis by carvedilol
60. Cardiotrophin 1 (CT-1) inhibition of cardiac myocyte apoptosis via a mitogen-activated protein kinase-dependent pathway
61. Ceramide is involved in triggering of cardiomyocyte apoptosis induced by ischemia and reperfusion
62. Fibroblast growth factor-1 prevents myocardial apoptosis triggered by ischemia reperfusion injury
63. Insulin-like growth factor-1 attenuates the detrimental impact of nonocclusive coronary artery constriction on the heart
64. Attenuation of ischemia/reperfusion injury in rats by a caspase inhibitor
65. Calpain inhibitor-1 reduces infarct size and DNA fragmentation of myocardium in ischemic/reperfused rat heart
66. Caspase inhibition reduces myocyte cell death induced by myocardial ischemia and reperfusion in vivo
67. Inhibition of apoptosis after ischemia-reperfusion in rat myocardium by cycloheximide
68. Delayed myocardial preconditioning by alpha-1-adrenoceptors involves inhibition of apoptosis
69. A rapid ischemia-induced apoptosis in isolated rat hearts and its attenuation by the sodium-hydrogen exchange inhibitor HOE 642 (cariporide)
70. The role of the myocardial sodium-hydrogen exchanger in mediating ischemic and reperfusion injury. From amiloride to cariporide
71. Mast cells cause apoptosis of cardiomyocytes and proliferation of other intramyocardial cells in vitro
72. Apoptosis in myocytes in end-stage heart failure
73. Apoptosis in the failing human heart
74. Cardiomyocyte apoptosis and progression of heart failure to transplantation
75. Evidence of apoptosis in arrhythmogenic right ventricular dysplasia
76. Troponin T cross-linking in human apoptotic cardiomyocytes
77. In vivo evidence of apoptosis in arrhythmogenic right ventricular cardiomyopathy
78. The role of apoptosis in dilated cardiomyopathy
79. Cell death in acromegalic cardiomyopathy
80. Overexpression of insulin-like growth factor in mice protects from myocyte death after infarction, attenuating ventricular dialtion, wall stress, and cardiac hypertrophy
81. Signaling pathway for cardiac hypertrophy and failure
82. Myocardial cell death in fibrillating and dilated human right atria
83. Dilated cardio-myopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-alpha
84. Cytokines and cardiomyocyte death
85. Mechanisms and models of heart failure. A combinatorial approach
86. Apoptosis in heart failure: Release of cytochrome c from mitochondria and activation of caspase-3 in human cardiomyopathy
87. Fas expression and apoptosis correlate with cardiac dysfunction in patients with dilated cardio-myopathy
88. Alternative splicing of the primary Fas transcript generating soluble Fas antagonists is suppressed in the failing human ventricular myocardium
89. Plasma Fas ligand, an inducer of apoptosis, and plasma soluble Fas, an inhibitor of apoptosis, in patients with chronic congestive heart failure
90. Increased cardiomyocyte apoptosis during the transition to heart failure in the spontaneously hypertensive rat
91. Elevated DNAse activity and caspase expression in association with apoptosis in failing ischemic sheep left ventricles
92. Contribution of non-cardiomyocyte apoptosis to cardiac remodelling that occurs in the transition from compensated hypertrophy to heart failure in spontaneously hypertensive rats
93. Enhanced G alpha q signaling: A common pathway mediates cardiac hypertrophy and apoptotic heart failure
94. Loss of a gp130 cardiac muscle ceil survival pathway is a critical event in the onset of heart failure during biomechanical stress
95. Evidence of cardiocyte apoptosis in myocardium of dogs with chronic heart failure
96. Myocyte nuclear mitotic division and programmed myocyte cell death characterize the cardiac myopathy induced by rapid ventricular pacing in dogs
97. Pacing-induced heart failure in dogs enhances the expression of p53 and p53-dependent genes in ventricular myocytes
98. Cardiomyocyte apoptosis and cardiac angiotensin-converting enzyme in spontaneously hypertensive rats
99. Effects of ACE inhibition on cardiomyocyte apoptosis in dogs with heart failure
100. The cellular and physiologic effects of beta blockers in heart failure
101. Safety and efficacy of a soluble p75 tumor necrosis factor receptor (Enbrel, etanercept) in patients with advanced heart failure
102. Tumor necrosis factor in the heart
103. Cell death in the failing heart: Role of an unnatural growth reponse to overload
104. The effects of norepinephrine on myocardial biology: Implications for the therapy of heart failure
105. Altered levels of mRNA of apoptosis-mediating genes after midterm mechanical ventricular support in dilative cardiomyopathy - First results of the Halle Assist Induced Recovery Study (HAIR)
106. Myocardial gene expression of regulators of myocyte apoptosis and myocyte calcium homeostasis during hemodynamic unloading by ventricular assist devices inpatients with end-stage heart failure
107. Ultrastructural quantitation of mitochondria and myofilaments in cardiac muscle from 10 different animal species including man
108. Normal and abnormal consequences of apoptosis in the human heart
109. Rekindling the mitochondrial fire